Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment

Frontiers in Oncology(2022)10.3389/fonc.2022.866014Source: DataRank Database

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 301 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access301 citations

Download PDF

Cite:

Linked data & code

gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 23.34)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Daniel Doheny ORCID,Grace L. Wong ORCID,Hui‐Wen Lo ORCID,Sara G. Manore ORCID

Live enrichment

PubMed:35371975 PMC:PMC8964978 OpenAlex:https://openalex.org/W4220981167

NCI NIH HHS

Grant: R01 CA228137

National Institutes of Health

Grant: 3P30CA012197-46S1

Cancer Center Support Grant

National Institutes of Health

Grant: 1F31CA261027-01A1

Developing Pharmacological tGLI1 Inhibitors

National Institutes of Health

Grant: 1R01CA228137-01A1

Roles of tGLI1 and microRNA Network in Breast Cancer Brain Metastasis

National Institutes of Health

Congressionally Directed Medical Research Programs

FWCI

23.34

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fonc.2022.866014/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.866014/pdf

journalhttps://doi.org/10.3389/fonc.2022.866014

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35371975

repositoryhttps://doaj.org/article/d6087abb4d814e298db9c164d2c81690

Fields of Study

Cytokine Signaling Pathways and InteractionsHER2/EGFR in Cancer ResearchCancer Mechanisms and Therapy0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Cancer researchBreast cancerMetastasisSTAT3Glycoprotein 130STAT proteinJanus kinaseSignal transductionCancerBiologyMedicineCytokineImmunologyInternal medicineCell biologyInterleukin-6TherapeuticsJaksOncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being